Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Cecília Arraes"'
Publikováno v:
Journal of Clinical Oncology. 37:e16114-e16114
e16114 Background: Clear cell renal cell carcinoma (RCC) accounts for 3% of all cancers in Brazil, and the majority of these patients (pts) are treated in our public health system, SUS. Sunitinib and Pazopanib were incorporated into SUS in early 2019